COL18A1 and type 2 diabetes mellitus: Increased serum endostatin was identified as a predictor of progression to end‐stage kidney disease in a very large cohort (754 individuals) of patients with type 1 and type 2 diabetes using the SOMAscan platform [161], thus confirming previous associations with diabetic kidney disease severity and mortality in patients with type 2 diabetes [162, 163, 164].